CARACTERÍSTICAS EMPREENDEDORAS DE ENFERMEIRAS: UM ESTUDO NO SUL DO BRASIL by Deciane Pintanela de Carvalho, Helena Heidtmann Vaghetti, Jennifer Specht Dias, Laurelize Pereira Rocha

Get full text

89 First-in-human CAR T targets cleaved MUC1, the growth factor receptor form by Benoit Smagghe, Andrew Stewart, Pengyu Huang, Tyler Swanson, Danica Page, Mark Carter, Trevor Grant, Jennifer Specht, Cynthia Bamdad

Construction and validation of a tool to assess nursing interpersonal relations by Jennifer Specht Dias, Laurelize Pereira Rocha, Deciane Pintanela de Carvalho, Jamila Geri Tomaschewski-Barlem, Edison Luiz Devos Barlem, Graziele de Lima Dalmolin

Get full text

635 A phase 1, first in human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressin... by Yuan Yuan, Michael Klichinsky, Saar Gill, Melissa Johnson, Thomas Condamine, Jennifer Specht, Richard T Maziarz, Kim Reiss, Debora Barton, Daniel Cushing, Joanne Mortimer, Paula R Pohlmann, E Claire Dees, Naoto Ueno, Mathew Angelos, Ramona F Swaby, Yara Abdou

754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small c... by Haven Garber, Saranya Chumsri, Yazan Migdady, Chul Kim, Erika Hamilton, Jennifer Specht, Babar Bashir, Hirva Mamdani, Heidi Gillenwater, Yeonhee Kim, David R Spigel, Usama Gergis, Hemant S Murthy, Lubna N Chaudhary, Sarah Fitzsimmons, Bishwa J Ganguly, Hajime Hiraragi, Helle Jensen, Mary C Lessig

636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell... by Marcela Maus, Caron Jacobson, Frederick L Locke, Oliver Dorigo, David Maloney, Jennifer Specht, Saurabh Dahiya, Edward Garon, Diane M Simeone, John Welch, Kedar Kirtane, Marwan Fakih, Julian Molina, Ariane Lozac’hmeur, J Randolph Hecht, Jong Chul Park, Caleb Smith, Theodore Welling, M Pia Morelli, Patrick M Grierson, Tomislav Dragovich, William Y Go, Eric W Ng, Peter Vu, Jessica Tebbets, Gayanie Ong

634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss... by Sarah Nikiforow, Yi Lin, Marcela Maus, Armen Mardiros, Frederick L Locke, Scott Kopetz, Matthew Frigault, David Maloney, Jeffrey Ward, Jennifer Specht, Edward Garon, Diane M Simeone, John Welch, Kedar Kirtane, Marwan Fakih, Julian Molina, Kirstin Liechty, Ariane Lozac’hmeur, J Randolph Hecht, Caleb Smith, Salman R Punekar, Theodore Welling, M Pia Morelli, Patrick M Grierson, Sandip P Patel, Wen-Kai Weng, Tomislav Dragovich, Judy Vong, William Y Go, Eric W Ng